Ironwood, AbbVie win U.S. label expansion for Linzess in pediatric constipation
Ironwood Pharmaceuticals, Inc. - Class A · PHARMACEUTICAL PREPARATIONS · Now $3.57
-8.0% in 1d after detection
Post-detection moves
1h
-1.3%
1d
-8.0%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS